2/25
03:40 pm
crl
Charles River Laboratories International (CRL) had its price target raised by UBS Group AG from $170.00 to $175.00. They now have a "neutral" rating on the stock.
Low
Report
Charles River Laboratories International (CRL) had its price target raised by UBS Group AG from $170.00 to $175.00. They now have a "neutral" rating on the stock.
2/25
07:17 am
crl
IQVIA Signs Agreement to Acquire Drug Discovery Assets from Charles River Laboratories, Expanding End-to-End Drug Discovery Capabilities [Yahoo! Finance]
Low
Report
IQVIA Signs Agreement to Acquire Drug Discovery Assets from Charles River Laboratories, Expanding End-to-End Drug Discovery Capabilities [Yahoo! Finance]
2/25
07:17 am
crl
Charles River Laboratories Provides Update on Planned Divestitures [Yahoo! Finance]
Low
Report
Charles River Laboratories Provides Update on Planned Divestitures [Yahoo! Finance]
2/25
07:00 am
crl
Charles River Laboratories Provides Update on Planned Divestitures
Low
Report
Charles River Laboratories Provides Update on Planned Divestitures
2/24
02:53 pm
crl
Baird Maintains Outperform Rating on Charles River Laboratories International, Inc. (CRL) [Yahoo! Finance]
Low
Report
Baird Maintains Outperform Rating on Charles River Laboratories International, Inc. (CRL) [Yahoo! Finance]
2/20
10:58 am
crl
Charles River Laboratories International (NYSE:CRL) had its "buy" rating reaffirmed by analysts at TD Cowen.
Low
Report
Charles River Laboratories International (NYSE:CRL) had its "buy" rating reaffirmed by analysts at TD Cowen.
2/20
10:01 am
crl
Charles River Laboratories International (NYSE:CRL) was given a new $175.00 price target on by analysts at Mizuho.
Low
Report
Charles River Laboratories International (NYSE:CRL) was given a new $175.00 price target on by analysts at Mizuho.
2/19
12:08 pm
crl
Charles River Laboratories International (NYSE:CRL) was given a new $193.00 price target on by analysts at Robert W. Baird.
Medium
Report
Charles River Laboratories International (NYSE:CRL) was given a new $193.00 price target on by analysts at Robert W. Baird.
2/19
07:20 am
crl
Charles River Laboratories International (NYSE:CRL) had its "overweight" rating reaffirmed by analysts at Barclays PLC.
Medium
Report
Charles River Laboratories International (NYSE:CRL) had its "overweight" rating reaffirmed by analysts at Barclays PLC.
2/18
01:02 pm
crl
Charles River Laboratories International Q4 Earnings Call Highlights [Yahoo! Finance]
Low
Report
Charles River Laboratories International Q4 Earnings Call Highlights [Yahoo! Finance]
2/18
12:51 pm
crl
Charles River Laboratories International, Inc. Q4 2025 Earnings Call Summary [Yahoo! Finance]
Low
Report
Charles River Laboratories International, Inc. Q4 2025 Earnings Call Summary [Yahoo! Finance]
2/18
07:01 am
crl
Charles River Laboratories Announces Executive Appointments
Low
Report
Charles River Laboratories Announces Executive Appointments
2/18
07:00 am
crl
Charles River Laboratories Announces Fourth-Quarter and Full-Year 2025 Results and Provides 2026 Guidance
Low
Report
Charles River Laboratories Announces Fourth-Quarter and Full-Year 2025 Results and Provides 2026 Guidance
2/16
10:16 pm
crl
Charles River Laboratories (CRL) Q4 Earnings: What To Expect [Yahoo! Finance]
Medium
Report
Charles River Laboratories (CRL) Q4 Earnings: What To Expect [Yahoo! Finance]
2/12
11:54 am
crl
Halper Sadeh LLC Encourages Charles River Laboratories International, Inc. Shareholders to Contact the Firm to Discuss Their Rights
Medium
Report
Halper Sadeh LLC Encourages Charles River Laboratories International, Inc. Shareholders to Contact the Firm to Discuss Their Rights
2/9
12:26 pm
crl
Charles River Laboratories (CRL): Buy, Sell, or Hold Post Q3 Earnings? [Yahoo! Finance]
Low
Report
Charles River Laboratories (CRL): Buy, Sell, or Hold Post Q3 Earnings? [Yahoo! Finance]
2/3
09:42 am
crl
In-Vitro Toxicology Testing Market to Reach US$ 57.55 Billion by 2033 Supported by OECD Guidelines, EPA NAM Framework, and EU Cosmetics Regulation Says Astute Analytica [Yahoo! Finance]
Medium
Report
In-Vitro Toxicology Testing Market to Reach US$ 57.55 Billion by 2033 Supported by OECD Guidelines, EPA NAM Framework, and EU Cosmetics Regulation Says Astute Analytica [Yahoo! Finance]
1/22
10:58 am
crl
Charles River Laboratories International (NYSE:CRL) had its "buy" rating reaffirmed by analysts at TD Cowen.
Low
Report
Charles River Laboratories International (NYSE:CRL) had its "buy" rating reaffirmed by analysts at TD Cowen.
1/21
04:30 pm
crl
Charles River Laboratories Schedules Fourth-Quarter 2025 Earnings and 2026 Guidance Release and Conference Call
Low
Report
Charles River Laboratories Schedules Fourth-Quarter 2025 Earnings and 2026 Guidance Release and Conference Call
1/21
08:40 am
crl
Charles River Enters Manufacturing Collaboration with Gazi University [Yahoo! Finance]
Low
Report
Charles River Enters Manufacturing Collaboration with Gazi University [Yahoo! Finance]
1/21
08:00 am
crl
Charles River Enters Manufacturing Collaboration with Gazi University
Low
Report
Charles River Enters Manufacturing Collaboration with Gazi University
1/20
03:39 pm
crl
Charles River Laboratories Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Charles River Laboratories International, Inc. - CRL
Low
Report
Charles River Laboratories Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Charles River Laboratories International, Inc. - CRL
1/19
09:04 am
crl
What to Expect From Charles River Laboratories' Next Quarterly Earnings Report [Yahoo! Finance]
Low
Report
What to Expect From Charles River Laboratories' Next Quarterly Earnings Report [Yahoo! Finance]
1/16
07:05 am
crl
Charles River Laboratories International (NYSE:CRL) had its "buy" rating reaffirmed by analysts at Citigroup Inc..
Low
Report
Charles River Laboratories International (NYSE:CRL) had its "buy" rating reaffirmed by analysts at Citigroup Inc..
1/16
05:41 am
crl
Here's Why Charles River Laboratories (CRL) is a Great Momentum Stock to Buy [Yahoo! Finance]
Low
Report
Here's Why Charles River Laboratories (CRL) is a Great Momentum Stock to Buy [Yahoo! Finance]